These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3308664

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is hepatic glycogen content a regulator of glucagon secretion?
    Kabadi UM.
    Metabolism; 1992 Feb; 41(2):113-5. PubMed ID: 1736031
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
    Kabadi UM, Eisenstein AB, Tucci J, Pellicone J.
    Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis.
    Petrides AS, De Fronzo RA.
    Metabolism; 1994 Jan; 43(1):85-9. PubMed ID: 8289679
    [Abstract] [Full Text] [Related]

  • 9. Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
    Sherwin R, Joshi P, Hendler R, Felig P, Conn HO.
    N Engl J Med; 1974 Jan 31; 290(5):239-42. PubMed ID: 4808927
    [No Abstract] [Full Text] [Related]

  • 10. Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
    Kabadi UM, Kabadi MU, Premachandra BN.
    Am J Gastroenterol; 1991 Oct 31; 86(10):1504-7. PubMed ID: 1928046
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ, Dupre J, Caussignac Y, Radziuk J, Van Vliet S.
    Metabolism; 1979 Apr 31; 28(4):300-7. PubMed ID: 449682
    [Abstract] [Full Text] [Related]

  • 14. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis.
    Petersen KF, Krssak M, Navarro V, Chandramouli V, Hundal R, Schumann WC, Landau BR, Shulman GI.
    Am J Physiol; 1999 Mar 31; 276(3):E529-35. PubMed ID: 10070020
    [Abstract] [Full Text] [Related]

  • 15. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F, Bernardi M, Arienti V, Scrivano P, Mazziotti A, Cavallari A, Patrono D, Piazzi S, Gozzetti G, Gasbarrini G.
    Hepatology; 1994 Feb 31; 19(2):329-38. PubMed ID: 8294090
    [Abstract] [Full Text] [Related]

  • 16. Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
    Clore JN, Blackard WG.
    Diabetes; 1994 Feb 31; 43(2):256-62. PubMed ID: 8288050
    [Abstract] [Full Text] [Related]

  • 17. Effects of supranormal liver glycogen content on hyperglucagonemia-induced liver glycogen breakdown.
    Bélanger P, Couturier K, Latour MG, Lavoie JM.
    Eur J Appl Physiol; 2000 Nov 31; 83(4 -5):328-35. PubMed ID: 11138571
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glucagon and glucose tolerance in liver cirrhosis.
    Greco AV, Altomonte L, Ghirlanda G, D'Anna LM, Manna R, Caputo S, Uccioli L.
    Acta Endocrinol (Copenh); 1988 Jul 31; 118(3):337-45. PubMed ID: 2899368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.